Skip to main content
American Journal of Physiology - Renal Physiology logoLink to American Journal of Physiology - Renal Physiology
. 2010 Oct 13;300(1):F49–F59. doi: 10.1152/ajprenal.00349.2010

Expression and distribution of transient receptor potential (TRP) channels in bladder epithelium

Weiqun Yu 1,4, Warren G Hill 2, Gerard Apodaca 4,, Mark L Zeidel 3
PMCID: PMC3023226  PMID: 20943764

Abstract

The urothelium is proposed to be a sensory tissue that responds to mechanical stress by undergoing dynamic membrane trafficking and neurotransmitter release; however, the molecular basis of this function is poorly understood. Transient receptor potential (TRP) channels are ideal candidates to fulfill such a role as they can sense changes in temperature, osmolarity, and mechanical stimuli, and several are reported to be expressed in the bladder epithelium. However, their complete expression profile is unknown and their cellular localization is largely undefined. We analyzed expression of all 33 TRP family members in mouse bladder and urothelium by RT-PCR and found 22 specifically expressed in the urothelium. Of the latter, 10 were chosen for closer investigation based on their known mechanosensory or membrane trafficking functions in other cell types. Western blots confirmed urothelial expression of TRPC1, TRPC4, TRPV1, TRPV2, TRPV4, TRPM4, TRPM7, TRPML1, and polycystins 1 and 2 (PKD1 and PKD2) proteins. We further defined the cellular and subcellular localization of all 10 TRP channels. TRPV2 and TRPM4 were prominently localized to the umbrella cell apical membrane, while TRPC4 and TRPV4 were identified on their abluminal surfaces. TRPC1, TRPM7, and TRPML1 were localized to the cytoplasm, while PKD1 and PKD2 were expressed on the apical and basolateral membranes of umbrella cells as well as in the cytoplasm. The cellular location of TRPV1 in the bladder has been debated, but colocalization with neuronal marker calcitonin gene-related peptide indicated clearly that it is present on afferent neurons that extend into the urothelium, but may not be expressed by the urothelium itself. These findings are consistent with the hypothesis that the urothelium acts as a sentinel and by expressing multiple TRP channels it is likely it can detect and presumably respond to a diversity of external stimuli and suggest that it plays an important role in urothelial signal transduction.

Keywords: mechanotransduction, umbrella cells


the bladder epithelium, or urothelium, is a stratified epithelial tissue composed of basal, intermediate, and umbrella cell layers. The latter is a single layer of highly differentiated and polarized cells that have tight junctions and a highly impermeable apical plasma membrane, which contains uroplakin proteins assembled into paracrystalline arrays, and can expand and contract in size as the bladder fills and empties. Combined, these features contribute to a compliant tight barrier that prevents diffusion of urine constituents into the underlying tissue (23, 24, 37). In addition to its role as a barrier, the umbrella cell and subjacent intermediate and basal cell layers also have a sensory function and in response to various physical and chemical stimuli can release neurotransmitters (such as ATP and nitric oxide), which then communicate the state of the tissue's external environment to afferent neurons (3, 4). The response to mechanical and other stimuli may depend, in part, on the function of umbrella cell-associated ion channels, which when opened or closed can alter membrane potential (32, 61). Possible sensory channels include the epithelial sodium channel (ENaC), various mechanically sensitive potassium channels (33, 61), and nonselective cation channels whose identity are unknown but may play an important role in mechanotransduction (55, 61). Other potential ion channels with sensory activity expressed by the umbrella cells and the other urothelial cell layers include the purinergic P2X family channels and members of the transient receptor potential (TRP) family of channels.

TRP channels respond to a diversity of stimuli including mechanical forces, heat, osmotic stress, and a broad array of chemical compounds (14, 60), and may also play important roles in human physiology, pathology, and inherited diseases (43). The superfamily includes 33 members and in higher metazoans it is divided into 6 subfamilies: TRPC (canonical), TRPV (vanilloid), TRPM (melastatin), TRPA (ankyrin), TRML (mucolipin) and TRPP (polycystin). As examples, TRPV4 has been shown to play a role in pressure and osmotic sensation in blood vessels, airways, and renal vasculature and TRPM5, which is expressed in taste receptor cells throughout the oral cavity, is important for the perception of sweet, amino acid, and bitter tastes. TRP members also play important roles in human disease. Six mutations of the TRPC6 gene have been linked to the human proteinuric kidney disease known as focal and segmental glomerulosclerosis (FSGS), in which effacement of the podocyte foot processes causes the glomerular slit diaphragms to lose their integrity. Mutations in PKD1 and PKD2 (also known as polycystins 1 and 2) cause decreased Ca2+ influx into renal epithelial primary cilia, and can lead to polycystic kidney disease (PKD), which is characterized by the progressive development of large fluid-filled cysts in the kidney and ultimately organ failure (20, 25).

TRP family channels are likely to play important roles in regulating urothelial sensory perception and overall bladder function. For example, TRPV1−/− mice have abnormal bladder function characterized by a high frequency of low-amplitude, nonvoiding bladder contractions (10), and TRPV4−/− mice have few voiding contractions, and like TRPV1−/− mice have a higher frequency of non-voiding contractions (21). Furthermore, both of these TRP knockout mice show decreased ATP release upon distention of their bladders, possibly implicating TRPV1 and TRPV4 in bladder mechanotransduction. Other TRP channels that may be expressed in the urothelium include TRPA1, TRPM7, TRPM8, and TRPV2 (8, 18, 58). However, the expression and function of these TRP channels in the urothelium are not well understood, and there is little or no information about the expression and distribution of the other 27 TRP family members in the bladder proper. In this paper, we have defined the expression profile of the entire family of 33 TRP channels in whole bladder and in the urothelium by RT-PCR. Furthermore, we have performed cellular and subcellular immunolocalization of 10 TRP channels implicated in mechanosensation and membrane trafficking in urothelium and other tissues. We show that messenger RNA for 22 TRPs is expressed in the urothelium, and immunolocalization studies indicate a polarized distribution of TRPs on umbrella cells and urothelium. Our data further support the hypothesis that the urothelium is a dynamic sensory tissue that detects changes in the external environment through expression of multiple receptors and ion channels.

MATERIALS AND METHODS

Materials

Unless otherwise specified, all chemicals were obtained from Sigma (St. Louis, MO) and were of reagent grade or better.

Animals

Animals used in this study were Sprague-Dawley rats (weighing 250–300 g), and C57BL/6J mice (19–21 g). Rats and mice were euthanized by inhalation of 100% CO2. After euthanasia and thoracotomy, the bladders were rapidly excised and processed as described below. All animal studies were carried out with the approval of the Beth Israel Deaconess Medical Center and University of Pittsburgh Institutional Animal Care and Use Committees.

Antibodies and Labeled Probes

Affinity-purified rabbit polyclonal anti-TRPC1 antibody and the corresponding control peptide were purchased from Sigma. Affinity-purified rabbit polyclonal anti-TRPC4 antibody and the corresponding control peptide were purchased from Alomone Labs (Jerusalem, Israel). Affinity-purified rabbit polyclonal anti-TRPV1 antibody and the corresponding control peptide were purchased from Enzo Life Sciences (Plymouth Meeting, PA). Affinity-purified rabbit polyclonal anti-TRPV2 antibody was a kind gift from Dr. David E. Clapham's laboratory (Children's Hospital of Boston, Boston, MA) (52). Affinity-purified rabbit polyclonal anti-TRPV4 antibody was a kind gift from Dr. David M. Cohen's laboratory (Oregon Health and Science University, Portland, OR) (54, 56, 57). Affinity-purified goat polyclonal anti-TRPM4 antibody (G-20) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal anti-TRPM4 whole serum was purchased from Abcam (Cambridge, MA). Affinity-purified goat polyclonal anti-TRPM7 antibody was purchased from Abcam. Affinity-purified rabbit polyclonal anti-TRPM7 antibody was also a kind gift from Dr. David E. Clapham's Laboratory (Children's Hospital of Boston) (30). Affinity-purified mouse monoclonal IgG1 anti-TRPM7 antibody was purchased from NeuroMab (Davis, CA). Rabbit polyclonal anti-PKD1 and anti-PKD2 anti-serums were kind gifts from Dr. Oxana Ibraghimov-Beskrovnaya's laboratory (Genzyme, Cambridge, MA) (20). An affinity-purified rabbit polyclonal anti-PKD1 antibody (NM005) was a gift from Dr. Angela Wandinger-Ness's laboratory (University of New Mexico) (47). Affinity-purified rabbit polyclonal anti-TRPML1 antibody was a gift from Dr. Kirill Kiselyov's laboratory (University of Pittsburgh) (28). Affinity-purified goat polyclonal anti-PGP9.5 antibody was purchased from Santa Cruz Biotechnology. Affinity-purified goat polyclonal anti-calcitonin gene-related peptide (CGRP) antibody was purchased from Abcam. Secondary donkey anti-rabbit/goat/rat/mouse antibodies conjugated to Alexa or horseradish peroxidase, and Topro-3 and rhodamine-phalloidin were purchased from Invitrogen-Molecular Probes (Carlsbad, CA).

RT-PCR Analysis

Excised bladders were placed in 1 ml lysis solution in a tissue grinder, and whole bladder RNA was extracted by an RNAqueous-4PCR kit following the manufacturer's protocol (Ambion, Austin, TX). Alternatively, the bladder was turned inside out onto a plastic rod, and urothelium was recovered by immersion into RNA lysis buffer for 2 min. RNA samples were treated with DNase I to remove potential genomic DNA contamination, and control reactions were performed in the absence of reverse transcriptase or in the presence of housekeeping gene primers (Fig. 1C). Reverse transcription was carried out according to instructions for the RETROscript (Ambion) kit using the standard PCR protocol. Primer pairs for each TRP channel are shown in Table 1. PCR products were run on a 2.0% (wt/vol) agarose gel and then stained with ethidium bromide to visualize the PCR products. Products were compared with a 100-bp ladder (PGC Scientific, Frederick, MD), which was used to estimate the size of the reaction products. The PCR products were excised from the gels, purified using a MiniElute Kit (Qiagen), and the sequence was verified by automated sequencing (GENEWIZ, Sotuh Plainfield, NJ).

Fig. 1.

Fig. 1.

Expression of transient receptor potential (TRP) channels in mouse bladder and urothelium. A: expression of message for the indicated TRP channels was detected by RT-PCR from total RNA isolated from mouse bladder. Specific TRP channel primers are given in Table 1. RT-PCR products were resolved on 2% agarose gels and visualized by staining with ethidium bromide. Numbers above or beneath the DNA bands are expected product sizes (in bp). B: RT-PCR analysis of TRP channel expression in RNA isolated from the urothelium. C: RT-PCR were performed in the absence of reverse transcriptase (left lane) or in the presence of a housekeeping gene primer (right lane) to ensure the quality of RNA and PCR. D: for TRP channels not detected in whole bladder, RT-PCR analysis was performed using RNA from positive control tissues including brain, kidney, and heart.

Table 1.

Primers used for PCR of TRP channels

TRP Channel Sequence of Primers (5′-3′) Expected Product Size, bp
TRPC1 CCTGTTATTTTAGCTGCTCATC 238
TAAGTTCAAACGCTCTCAGAAT
TRPC2 AGAAACAGTTTGTAGCACATCC 250
AAGAAGATAAGGAACCACAGGT
TRPC3 AAGCCCAGTATTAATGTCACTG 224
CTACTCAGTGATGGTCTCTCGT
TRPC4 TTTCCTTACTGCCTTTCAGTTA 168
CGGTAATTAAGAATGATTTCCA
TRPC5 AACAAGTTACAACTCGGCTCTA 247
AAAAGGCAAATGATAATGACAG
TRPC6 AGACCGTTCATGAAGTTTGTAG 225
TTCTTTACATTCAGCCCATATC
TRPC7 AGAATCAAGATGTGCCTCATAG 247
CATTGACTTCATCGTTCTCTCT
TRPV1 AGCGAGTTCAAAGACCCAGA 233
TTCTCCACCAAGAGGGTCAC
TRPV2 TGATGAAGGCTGTGCTGAAC 175
CACCACAGGCTCCTCTTCTC
TRPV3 TGAGATCCTGAAGTACATCCTC 245
ATTTCTTCCATTTCGTGTGTAG
TRPV4 AGAAAGGTCGTGGAGAAGCA 174
ATCAGTCAGGCGCTTCTTGT
TRPV5 TTGGTGCCTCTCGCTACTTT 249
AGCGCAGTAGGTCTCCAAAA
TRPV6 TTGAGCATGGAGCTGACATC 178
GGGGTGAGTCCCTGGTTATT
TRPM1 AATGGAGATGTCAAGTTCAAAG 191
TGGCTTCACAGAGAGTAAGTTT
TRPM2 TGGCTTCTAAGAGGAAAGTACA 206
AGTCCTGAAGTTTTCCAAGATT
TRPM3 GGCAATCAAATATAGTCAAGGA 150
ATGTTAGATCTTCCCACCTTTT
TRPM4 AGTTCCCCCTGGACTATAACTA 196
CGCTTTAACATCTTCTCATCTC
TRPM5 AGAATGAAACTCATGTCTTTGG 173
GTTAGACCTAAATAGCCCCATC
TRPM6 GTGCAGACGTGGTATAAAATCT 249
TTCATCACCATTGTTGTTATTG
TRPM7 CCTCATGAAGACCATTTTCTAA 210
ACAACTGTAACCTTCCTCACAG
TRPM8 CGTTGTCTTCGCTTATTTCTAC 219
TTTGAGTCCAGTTGTCTAAACC
TRPA1 CCACATGACAGAAGTCCTAGTT 231
GCAGGAGTCTTACTGATCACAT
PKD1 CCCACTCAGTCTTCTGTGTTAT 176
CTTTGGTGGAGACAGTGTAGTT
PKD1L1 TTGTCTGACAGCCTAGAACTTT 243
GGAGCACATCTTTCCACTAATA
PKD1L2 TTGAAGACCTGGTAGACTATGG 215
GTTGTCAAAGAGGTACTGGAGA
PKD1L3 ACAAACATGACATCAGACACAC 192
CTGACTGGTTGAACTCTGAAAT
PKDREJ CCATGGTTACTAAATTTGCTGT 219
AAAGCCTCACATTGTACTCATC
PKD2 ACAGATGAGAGATGACTTGGAG 203
TCACCAGTACTTGGAACTCTTC
PKD2L1 ACAGCTCTGTGAAGTAGCATTT 200
GTTACTGGAACGTAGGAAGACA
PKD2L2 TACAGCAAGTACACAGTGGAAA 249
CAGGGAGAAATCAATAAAAACA
TRPML1 CCCTGATCACTAATTGAGAAAA 202
TAAAATCTGGTGGGTTTTAGTG
TRPML2 GATTTTCTGGAGTTGATGAAGA 188
TGTCTTGTAGTGCTGCTTACAG
TRPML3 GAAAATGCAGCAGAAGAGTTAC 233
TAATCTGTATTTTCCGGAGTTG

TRP, transient receptor potential.

Western Blot Analysis of TRP Channels in the Urothelium

Mouse or rat urothelial tissue was obtained by pinning the isolated bladder onto a rubber mat using pins and then gently scraping the epithelium with a cell scraper (17-mm scraper length; Sarstedt, Newton, NC). The cells were lysed in 0.5% SDS lysis buffer (50 mM triethanolamine, pH 8.6, 100 mM NaCl, 5 mM EDTA, and 0.5% wt/vol SDS) containing a protease inhibitor cocktail (5 μg/ml leupeptin, 5 μg/ml antipain, 5 μg/ml pepstatin, and 1 mM phenylmethylsulfonyl fluoride). Alternatively, cells were lysed in radioimmunoprecipitation assay buffer (RIPA; 50 mM Tris, pH 8.0, 150 mM NaCl, 1% vol/vol NP-40, 0.5% wt/vol deoxycholic acid, 0.1% wt/vol SDS) containing Complete Mini Protease Inhibitor Cocktail tablets (Roche). Proteins were resolved by SDS-PAGE and transferred to Immobilon-P, and the blots were probed with TRP channel-specific antibodies as previously described (62). Images were scanned with an ArtixScan 1800f flatbed scanner (Microtek International, Carson, CA), the contrast was corrected with Photoshop (San Jose, CA), and the images were imported into, and figures generated with Adobe Illustrator CS3 (San Jose, CA).

Immunofluorescence Labeling of TRP Channels in the Urothelium

Excised bladders were fixed in 4% wt/vol paraformaldehyde dissolved in 100 mM sodium cacodylate (pH 7.4) buffer for 2 h at room temperature. In some cases, tissue was fixed by 100% methanol (4°C) for 5 min or in 10% vol/vol acetic acid, 40% vol/vol ethanol in phosphate-buffered saline for 40 min at 4°C. Fixed tissue was cut into small pieces with a razor blade, cryoprotected, frozen, sectioned, and incubated with primary antibodies (1:100–1:500 dilution) for 2 h at room temperature as described previously (62). After washing away of unbound primary antibody, the sections were incubated with a mixture of Alexa 488-conjugated secondary antibody (diluted 1:100), rhodamine-phalloidin (1:50), and Topro-3 (1:1,000). The sections were washed with PBS, postfixed with 4% wt/vol paraformaldehyde, and mounted under coverslips with p-diaminobenzidine-containing mounting medium.

Scanning Laser Confocal Analysis of Fluorescently Labeled Cells

Imaging was performed on a TCS-SL confocal microscope equipped with argon and green and red helium-neon lasers (Leica, Deerfield, IL). Images were acquired by sequential scanning with a ×100 (1.4 numerical aperture) planapochromat oil objective and the appropriate filter combinations. Settings were as follows: photomultipliers set to 600–800 V, 1 Airy disk, and Kalman filter (n = 4). Serial (z) sections were captured with a 0.25-μm step size. The images (512 and 512 pixels) were saved as TIFF files. The OpenLab program (PerkinElmer) was used to project the serial sections into one image. The contrast level of the final images was adjusted in Adobe Photoshop, and the images were imported into Adobe Illustrator CS3.

RESULTS

Multiple TRP Channels are Expressed in Mouse Bladder and Urothelium

In our initial analysis we examined the mRNA expression profile of TRP channels in whole bladder and isolated urothelium. Mice were utilized in these studies because sequences for all of the TRP channels are known and because of the relative ease of future genetic manipulations in this animal model. Of 33 TRP members, we demonstrated that the majority (27) were expressed in whole bladder tissue by RT-PCR (Fig. 1A). These included five of seven TRPC members (TRPC1–5), five of six TRPV members (TRPV1–4 and TRPV6), seven of eight TRPM isoforms (TRPM1–7), seven of eight TRPPs (PKD1–2, PKD1L2–3, PKDREJ, and PKD2L1–2), and all three TRPML members (TRPML1–3). TRPA1 was not detected. Of these 27 proteins, 22 TRP members were expressed specifically in urothelium (Fig. 1B), including three of six TRPC members (TRPC1–2 and TRPC4), five of six TRPV members (TRPV1–4 and TRPV6), five of eight TRPMs (TRPM2 and TRPM4–7), seven of eight TRPPs (PKD1–2, PKD1L2–3, PKDREJ, and PKD2L1–2), and two of three TRPML members (TRPML1–2). Thus message for two thirds (22/33) of the TRP family was detected in urothelium by RT-PCR. For those six TRP members that were not detected in either whole bladder or urothelium, positive control reactions using brain, kidney, or heart tissues were performed and products of the expected sizes were observed (Fig. 1D), confirming that primers for these particular isoforms were able to amplify specific products from tissues known to express these proteins. These experiments thus establish that a rich diversity of TRP family members is expressed in the bladder and in the urothelium.

Western Blot Analysis Confirms Expression of TRP Channels in the Urothelium

Of the 22 TRP channels associated with the urothelium, we chose 10 for further analysis based on the availability of antibodies, and previous reports of their involvement in mechanotransduction, osmotic sensation, or membrane traffic (43, 60). Western blot analysis confirmed that TRPC1, TRPC4, TRPV1, TRPV2, TRPV4, TRPM4, TRPM7, TRPML1, PKD2, and PKD1 were expressed in the urothelium (Fig. 2). The TRPC1-specific antibody recognized a protein with an apparent molecular mass of ∼91 kDa (Fig. 2A), which is the nominal molecular mass of the protein, and control peptide totally abolished the signal. Similar to a previous report (53), a lower molecular mass protein species was also observed and may represent a TRPC1 proteolytic fragment. The anti-TRPC4 antibody detected a single protein species of ∼90 kDa (Fig. 2B). TRPC4 has four protein variants, with the full-length species containing 974 amino acids and a predicted molecular mass of ∼112 kDa. The protein species we observed is likely to be a variant that contains 564 amino acids and has been reported previously (19). The anti-TRPV1 antibody weakly detected a protein species of 75 kDa, and this binding was abolished by the control peptide (Fig. 2C). The anti-TRPV2 antibody detected a single protein species of ∼86 kDa (Fig. 2D), which is the predicted size of this protein. The anti-TRPV4 antibody we employed, which was used in several previous studies (54, 56, 57), detected a major protein species of 131 kDa (Fig. 2E). This is larger than the expected molecular mass of 98 kDa and represents tissue-specific glycosylation (56), or some other posttranslational processing event. We also detected a faint protein species at ∼82 kDa (Fig. 2E), which could be the smaller molecular variant of TRPV4 or a proteolytic fragment. There are three reported TRPM4 splice variants with predicted molecular masses of ∼136, ∼55, and ∼48 kDa. All three protein variants were apparently expressed in the urothelium (Fig. 2F). The anti-TRPM7 antibody detected a protein species of ∼250 kDa as previously reported (Fig. 2G) (30). The anti-TRPML1 antibody detected two protein species of ∼ 66 and ∼ 70 kDa (Fig. 2H), which are the nominal size of the two predicted splice variants of this protein. We also detected a small 36-kDa fragment, which may represent a cleaved form of TRPML1 (28). For PKD1, we detected a large protein species (∼500 kDa) that is consistent with the previously reported molecular mass of this protein in kidney epithelium (Fig. 2I) (47). Proteolytic processing of PKD1 can yield up to five cleaved fragments (35), and we observed three smaller molecular species with corresponding molecular mass that were close to the calculated molecular mass (Fig. 2I). The anti-PKD2 antibody, which was used in previous studies (20), detected two protein species with approximate molecular masses of 109 kDa (Fig. 2J). The larger protein species may represent a glycosylated species and has been described previously (12). Taken together, these results confirm that multiple TRP channel proteins are expressed in the urothelium.

Fig. 2.

Fig. 2.

Western blot analysis of select TRP channels in mouse urothelium. Lysates of mouse or rat urothelium (25 μg of protein) were resolved by SDS-PAGE, and Western blots were probed with antibodies specific for the indicated TRP channel. The major protein species are indicated on the left by arrowheads, and the migration of molecular size markers is indicated to the right of each panel.

TRP Channels are Expressed at the Cell Surface and Intracellularly in Bladder Urothelium

To define the cellular distribution of the TRP channels, bladder tissue was immunolabeled with the above TRP-specific antibodies and then examined by confocal microscopy. The tissue was also incubated with rhodamine-phalloidin and Topro-3 to label the cortical actin cytoskeleton (which defines cellular boundaries) and the nuclei, respectively. However, in tissues fixed with methanol or acetic acid the rhodamine-phalloidin did not stain well, and in these cases we incubated the tissues with anti-claudin 4 or anti-aquaporin-3 antibodies, which label the basolateral surface of the umbrella cells and the plasma membranes of the underlying intermediate and basal cell layers (see Fig. 3, A–C and H, for example) (1, 50).

Fig. 3.

Fig. 3.

Fig. 3.

Localization of TRP channels in mouse and rat urothelium. Cryosections of mouse (A–D, F, and G) or rat (E and H–J) bladder tissue were labeled with the indicated TRP channel antibodies (green) and either rhodamine phalloidin (D and G), or antibodies to claudin 4 (E and H–J) or aquaporin-3 (AQP3; A, B, C, and F; all displayed in red). Nuclei were labeled with ToPro-3 (blue). Far right: merged images. In some panels, a dashed white line indicates the apical surface of the umbrella cells. In B, TRPC4-positive fibrils below the basal cell layer are indicated by arrows. TRPV1-labeled filaments, likely afferent nerve processes, are indicated by asterisks in C. Scale bars = 10 μm.

Consistent with the RT-PCR data and Western blot analysis, all 10 TRP channels were localized within the urothelium (Fig. 3, A–J). TRPC1 labeled cytoplasmic structures in the umbrella cells, whereas much less staining was detected in the intermediate and basal cell layers (Fig. 3A). TRPC4 was distributed along the basolateral plasma membrane of the umbrella cells, but none was found along the apical membrane of these cells. In addition, TRPC4 was found on the surface of the intermediate and basal cells (Fig. 3B), and in fibrils below the basal cell layer that may be nerve fibers and possibly smooth muscle cells (arrows in Fig. 3B). Subsequent colocalization of TRPC4 with a specific neuron marker, PGP9.5, demonstrated that the TRPC4-positive fibrils were indeed nerve fibers (Fig. 4A). The TRPV1 antibody did not stain the urothelium but strongly labeled filamentous elements that were localized below and penetrated into the urothelium (Fig. 3C, asterisks). The signal was totally abolished by the control peptide. We felt these were likely to be the previously described TRPV1-positive afferent nerve fibers (5) and therefore tested this hypothesis in a colocalization experiment with a neuronal marker specific for afferent fibers, i.e, CGRP. As can be seen in Fig. 4B, there is precise colocalization of these two proteins, confirming that TRPV1 staining in urothelium is specific to nerve fibers.

Fig. 4.

Fig. 4.

Colocalization of TRPC4 and TRPV1 with neuron-specific markers, PGP9.5 and calcitonin gene-related peptide (CGRP) in bladder tissue. Bladder sections were labeled with the either TRPC4 (A) or TRPV1 (B) antibodies (green) and PGP9.5 or CGRP antibodies (red). Nuclei were labeled with ToPro-3 (blue). Far right: merged images. The colocalization of TRPC4/TRPV1 with PGP9.5/CGRP are indicated by arrows. Scale bars = 10 μm.

TRPV2 strongly labeled the apical plasma membrane of umbrella cells and was also present in the cytoplasm (Fig. 3D). However, there was no basolateral staining present in umbrella cells. TRPV4 was localized to the basolateral membrane of the umbrella cells and the plasma membrane of the intermediate and basal cells (Fig. 3E). TRPM4 was clearly localized to the apical but not basolateral plasma membrane of the umbrella cells (Fig. 3F). TRPM7 is ubiquitously expressed in many tissues, and we observed staining of TRPM7 in suburothelial tissues, possibly including fibroblasts and smooth muscle cells. It was abundantly expressed in the urothelium, with high expression in the umbrella cells (Fig. 3G). There was also some nuclear staining, which was confirmed by using two different antibodies and different staining treatments. TRPML1 was also strongly expressed in the urothelium and was distributed along the plasma membrane and on what appeared to be intracellular membranes, possibly lysosomes (Fig. 3H). PKD1 and PKD2 were found at the apical surface of the umbrella cells and along what appeared to be the plasma membranes, or closely apposed membranes, of the other cell layers (Fig. 3, I and J). In summary, multiple TRP channels were localized in the umbrella cells and urothelium with a polarized distribution pattern.

DISCUSSION

The bladder urothelium is proposed to serve as a sentinel that receives sensory input and responds in turn by release of mediators such as acetylcholine, adenosine, and ATP. These mediators then communicate the state of the urothelial extracellular environment to the underlying tissues (3, 4). A class of molecules that may play an important role in urothelial sensory function are the TRP family channels, of which six (TRPV1, TRPV2, TRPV4, TRPA1, TRPM7, and TRPM8) were previously identified in ex vivo or in vitro preparations of urothelium by RT-PCR, immunostaining, or functional assays (810, 18, 21). The goal of this study was to identify additional TRP family members that would further reveal the sensory repertoire of the urothelium. Using native urothelial tissue as a source, we detected message for a large number of TRPs in whole bladder with 27 of 33 family members expressed, and of these, 22 were also found in the urothelium. In the case of the 10 urothelial isoforms that were characterized in more detail, localization by immunofluorescence provided confirmation of their expression and distribution in the urothelium or associated tissues. For the remaining 12 TRPs, their expression should be treated with caution at this time.

Expression of TRPV1/2/4, TRPA1, and TRPM7/8 in the Urothelium

TRPV1/2/4, TRPM7/8, and TRPA1 were previously reported to be expressed in the urothelium (810, 18, 21). We confirmed the existence of TRPV1/2/4 and TRPM7 in whole bladder and urothelium, but we could not detect TRPA1 or TRPM8 using several sets of PCR primers or selective antibodies. Therefore, our work is in agreement with a recent publication that showed TRPM8 and TRPA1 mRNA expression is extremely low or undetectable in the urothelium (18).

Because of its sensitivity to heat, protons, and vanilloid compounds, and reported expression in the urothelium and subjacent afferent nerve fibers, TRPV1 has been proposed to act as an urothelial mechanosensor. However, urothelial expression has been questioned (17, 18, 59). In our studies, we detected relatively faint expression of TRPV1 by RT-PCR and Western blotting (Figs. 1B and 2C), and immunolocalization studies demonstrated distinctive staining of fibers that ran between and underneath urothelial cells, but no staining of the urothelium itself. The fibers were positively confirmed as neuronal processes by costaining with CGRP. At least for the antibody we employed in our studies, we find no evidence of urothelial TRPV1 expression and attribute the faint signals detected by RT-PCR and Western blotting to contamination of our urothelial preparations with afferent nerve fibers.

The expression of TRPV2 was recently described in primary cultures of urothelium and urothelial cancer cell lines (18, 58). Our studies expand on these findings by exploring the expression of this channel in native tissue. We observed that it is primarily expressed in umbrella cells, at or near the apical surface, with little signal detected in the intermediate and basal cell layers (Fig. 3D). TRPV2 responds to hypotonicity and mechanical stimuli in aortic myocytes (40) and transduces physical stimuli in mast cells through a protein kinase A-dependent pathway (51). In a similar fashion, the apically located TRPV2 may respond to stretch and stimulate urothelial membrane turnover and release of neurotransmitters.

Consistent with previous reports (21, 38), we observed that TRPV4 is localized at the basolateral plasma membrane of umbrella cells and the plasma membrane of intermediate and basal cells (Fig. 3E). TRPV4 appears to sense distension of the bladder and may modulate ATP release during the normal micturition reflex (38). TRPV4−/− mice exhibit an incontinent phenotype emphasizing an important role for this channel in bladder function (21). TRPV4 has also recently been shown to directly interact with the α2-integrin and the src tyrosine kinase and is proposed to act as a component of a molecular complex that functions in regulating the set point for inflammation during nerve injury (2). How TRPV4 in the urothelium senses mechanical force and contributes to the micturition reflex requires further study.

Expression of TRPC, TRPM, TRPML, and TRPP Family Members in the Urothelium

In addition to the TRPV subfamily, we also detected expression of TRPC, TRPM, TRPML, and TRPP subfamily members in the bladder and urothelium. TRPC1 is widely expressed in different tissues, including the brain, testis, ovaries, smooth muscle, endothelium, salivary glands, and liver (48). When TRPC1 is reconstituted in proteoliposomes, it is gated open by membrane stretch (36). However, it is apparently not an obligatory component of stretch-activated channel complexes in vascular smooth muscle cells (15). Therefore, it is not fully understood how TRPC1 responds to mechanical stimuli. TRPC1 is reported to be at the plasma membrane and at intracellular sites including the endoplasmic reticulum (ER) and Golgi apparatus (48). Although we observed little plasma membrane TRPC1 in the urothelium, this channel was abundantly expressed intracellularly in what may be the ER and/or Golgi. Interestingly, TRPC-4 or -5 can interact with TRPC1 to form a heteromer, which facilitates TRPC1 trafficking to the plasma membrane (7, 48). Therefore, TRPC1, possibly in a complex with TRPC4, may traffic to the umbrella cell plasma membrane in response to stretch and once there may contribute to mechanotransduction.

TRPC4 is intriguing because it colocalizes with junction-associated proteins including ZO-1, connexin 43, β-catenin, VE-cadherin, and the actin cytoskeleton to form a supramolecular signaling complex (22, 49). Indeed, it is recognized as an important cation channel in the vascular endothelium and smooth muscle and functionally responds to mechanical stretch through Ca2+ influx (22, 34). In the urothelium, TRPC4 was prominently localized to the plasma membrane of the basal/intermediate urothelium (Fig. 3B). Furthermore, there was clear localization of TRPC4 at lateral junctions of umbrella cells and cell-cell contacts, suggesting that TRPC4 might play an important role in urothelium adhesion and mechanotransduction.

Members of the TRPM family were also identified in the urothelium. TRPM4 is activated by membrane stretch and, as a result of monovalent cation conduction, elicits membrane depolarization and vasoconstriction in arterial myocytes (16, 39). TRPM4 also undergoes dynamic translocation from a vesicular pool to the plasma membrane in pancreatic β-cells and controls insulin secretion (13). In the urothelium, TRPM4 is localized to the apical membrane of the umbrella cells. Although nothing is known about its function in the urothelium, we speculate that it may function in umbrella cell apical membrane trafficking and depolarization upon mechanical stretch.

TRPM7 is a unique protein containing both ion channel and kinase activity. It is universally expressed and required for cell viability (41). In mice, knockout of TRPM7 is embryonically lethal (26). TRPM7 may reside in the synaptic vesicles of neurons, where it forms molecular complexes that facilitate neurotransmitter release (11, 30). It has recently been described as a mechanosensitive channel that translocates to the plasma membrane in response to shear stress (46) and may be directly gated by plasma membrane stretch (44, 45). We detected punctate staining of TRPM7 in umbrella cells, possibly in vesicles (Fig. 3G). It is therefore possible that in response to mechanical stretch TRPM7 may traffic to the plasma membrane where it may play an unknown role in mechanotransduction.

TRPML1 is present in late endosomes and lysosomes. Mutations of this gene cause mucolipidosis type IV (MLIV), an autosomal recessive, neurodegenerative lysosomal storage disorder (43). TRPML1 has been hypothesized to function in the late endocytic pathway, where it may regulate the ionic composition of late endosomes/lysosomes (6). We detected large numbers of TRPML1-positive vesicular structures in umbrella cells (Fig. 3H), which may represent late endosomes/lysosomes. Recent studies indicate that the major fate of endocytosed umbrella cell apical membranes is delivery to these degradative compartments (27). Thus TRPML may play an important role in umbrella cell apical membrane traffic and recycling and degradation of surface proteins.

Of significant interest is the expression of PKD1 and PKD2 in the urothelium. Mutations in PKD1, a >450-kDa protein with multiple extracellular domains, or PKD2, a nonselective cation channel, can result in various forms of PKD (42). These proteins interact with each other to form functional dimers, and PKD2 is also reported to form a heterodimer with TRPV4 (29). These proteins have been localized to the basolateral membrane and associated adhesion junctions, apically localized primary cilia, as well as intracellular organelles including the ER (20, 42, 47). PKD1 and PKD2 participate in cell-cell and cell-matrix interactions (47) and together form a nonselective cation channel that conducts Ca2+ in response to bending of primary cilia (42). Previous studies reported the expression of PKD1 in the urothelium, but no information was provided about its localization (25). We detected both PKD1 and PKD2 expression in the urothelium, and both localized prominently to the apical domain of the umbrella cells. Here, they may play some role in transducing sensory signals such as membrane stretch. Of some interest is the observation that the adult umbrella cell apical membrane lacks any cilia (3, 31), so apical PKD1/PKD2 function may not be confined solely to ciliary structures.

Summary

Once considered an inert barrier, the urothelium is now proposed to be a mechanosensor (4, 61). Our observation that 22 TRP channels may be expressed in this tissue provides additional support for this hypothesis. We further examined the subcellular localization of 10 TRP channels in the urothelium and found distinctive and nonredundant localization patterns: some family members resided on the apical membrane of umbrella cells, while others were on the basolateral membrane or present intracellularly. While the role of these channels in the urothelium is largely unknown, it is likely that they may act individually or as subunits of supramolecular signal complexes to detect changes in the extracellular milieu of the umbrella cells in both normal and abnormal bladder physiology. Thus the identification of the repertoire of urothelial TRP channels will direct investigators to promising molecular candidates for future studies.

GRANTS

We thank Dr. Bryce MacIver for insightful comments during the preparation of the manuscript.

DISCLOSURES

No conflicts of interest, financial or otherwise, are declared by the authors.

ACKNOWLEDGMENTS

This work was supported by National Institute of Diabetes and Digestive and Kidney Diseases Grants DK 083299 (W. G. Hill), DK 43955 (M. L. Zeidel), R37DK54425 (G. Apodaca), R01DK077777 (G. Apodaca), and the Pittsburgh Center for Kidney Research Urinary Tract Epithelial Imaging Core P30DK079307 (G. Apodaca), and an American Heart Association Predoctoral Fellowship (W. Yu).

REFERENCES

  • 1. Acharya P, Beckel J, Ruiz WG, Wang E, Rojas R, Birder L, Apodaca G. Distribution of the tight junction proteins ZO-1, occludin, and claudin-4, -8, and -12 in bladder epithelium. Am J Physiol Renal Physiol 287: F305–F318, 2004 [DOI] [PubMed] [Google Scholar]
  • 2. Alessandri-Haber N, Dina OA, Joseph EK, Reichling DB, Levine JD. Interaction of transient receptor potential vanilloid 4, integrin, and SRC tyrosine kinase in mechanical hyperalgesia. J Neurosci 28: 1046–1057, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Apodaca G. The uroepithelium: not just a passive barrier. Traffic 5: 117–128, 2004 [DOI] [PubMed] [Google Scholar]
  • 4. Apodaca G, Balestreire E, Birder LA. The uroepithelial-associated sensory web. Kidney Int 72: 1057–1064, 2007 [DOI] [PubMed] [Google Scholar]
  • 5. Avelino A, Cruz C, Nagy I, Cruz F. Vanilloid receptor 1 expression in the rat urinary tract. Neuroscience 109: 787–798, 2002 [DOI] [PubMed] [Google Scholar]
  • 6. Bach G. Mucolipin 1: endocytosis and cation channel—a review. Pflügers Arch 451: 313–317, 2005 [DOI] [PubMed] [Google Scholar]
  • 7. Berbey C, Weiss N, Legrand C, Allard B. Transient receptor potential canonical type 1 (TRPC1) operates as a sarcoplasmic reticulum calcium leak channel in skeletal muscle. J Biol Chem 284: 36387–36394, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Birder LA. TRPs in bladder diseases. Biochim Biophys Acta 1772: 879–884, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Birder LA, Kanai AJ, De Groat WC, Kiss S, Nealen ML, Burke NE, Dineley KE, Watkins S, Reynolds IJ, Caterina MJ. Vanilloid receptor expression suggests a sensory role for urinary bladder epithelial cells. Proc Natl Acad Sci USA 98: 13396–13401, 2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. Birder LA, Nakamura Y, Kiss S, Nealen ML, Barrick S, Kanai AJ, Wang E, Ruiz G, De Groat WC, Apodaca G, Watkins S, Caterina MJ. Altered urinary bladder function in mice lacking the vanilloid receptor TRPV1. Nat Neurosci 5: 856–860, 2002 [DOI] [PubMed] [Google Scholar]
  • 11. Brauchi S, Krapivinsky G, Krapivinsky L, Clapham DE. TRPM7 facilitates cholinergic vesicle fusion with the plasma membrane. Proc Natl Acad Sci USA 105: 8304–8308, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Cai Y, Maeda Y, Cedzich A, Torres VE, Wu G, Hayashi T, Mochizuki T, Park JH, Witzgall R, Somlo S. Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem 274: 28557–28565, 1999 [DOI] [PubMed] [Google Scholar]
  • 13. Cheng H, Beck A, Launay P, Gross SA, Stokes AJ, Kinet JP, Fleig A, Penner R. TRPM4 controls insulin secretion in pancreatic beta-cells. Cell Calcium 41: 51–61, 2007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Clapham DE. TRP channels as cellular sensors. Nature 426: 517–524, 2003 [DOI] [PubMed] [Google Scholar]
  • 15. Dietrich A, Kalwa H, Storch U, Mederos y Schnitzler M, Salanova B, Pinkenburg O, Dubrovska G, Essin K, Gollasch M, Birnbaumer L, Gudermann T. Pressure-induced and store-operated cation influx in vascular smooth muscle cells is independent of TRPC1. Pflügers Arch 455: 465–477, 2007 [DOI] [PubMed] [Google Scholar]
  • 16. Earley S, Straub SV, Brayden JE. Protein kinase C regulates vascular myogenic tone through activation of TRPM4. Am J Physiol Heart Circ Physiol 292: H2613–H2622, 2007 [DOI] [PubMed] [Google Scholar]
  • 17. Everaerts W, Sepulveda MR, Gevaert T, Roskams T, Nilius B, De Ridder D. Where is TRPV1 expressed in the bladder, do we see the real channel? Naunyn Schmiedebergs Arch Pharmacol 379: 421–425, 2009 [DOI] [PubMed] [Google Scholar]
  • 18. Everaerts W, Vriens J, Owsianik G, Appendino G, Voets T, De Ridder D, Nilius B. Functional characterization of transient receptor potential channels in mouse urothelial cells. Am J Physiol Renal Physiol 298: F692–F701, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Facemire CS, Mohler PJ, Arendshorst WJ. Expression and relative abundance of short transient receptor potential channels in the rat renal microcirculation. Am J Physiol Renal Physiol 286: F546–F551, 2004 [DOI] [PubMed] [Google Scholar]
  • 20. Foggensteiner L, Bevan AP, Thomas R, Coleman N, Boulter C, Bradley J, Ibraghimov-Beskrovnaya O, Klinger K, Sandford R. Cellular and subcellular distribution of polycystin-2, the protein product of the PKD2 gene. J Am Soc Nephrol 11: 814–827, 2000 [DOI] [PubMed] [Google Scholar]
  • 21. Gevaert T, Vriens J, Segal A, Everaerts W, Roskams T, Talavera K, Owsianik G, Liedtke W, Daelemans D, Dewachter I, Van Leuven F, Voets T, De Ridder D, Nilius B. Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding. J Clin Invest 117: 3453–3462, 2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Graziani A, Poteser M, Heupel WM, Schleifer H, Krenn M, Drenckhahn D, Romanin C, Baumgartner W, Groschner K. Cell-cell contact formation governs Ca2+ signaling by TRPC4 in the vascular endothelium: evidence for a regulatory TRPC4-beta-catenin interaction. J Biol Chem 285: 4213–4223 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Hu P, Deng FM, Liang FX, Hu CM, Auerbach AB, Shapiro E, Wu XR, Kachar B, Sun TT. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol 151: 961–972, 2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Hu P, Meyers S, Liang FX, Deng FM, Kachar B, Zeidel ML, Sun TT. Role of membrane proteins in permeability barrier function: uroplakin ablation elevates urothelial permeability. Am J Physiol Renal Physiol 283: F1200–F1207, 2002 [DOI] [PubMed] [Google Scholar]
  • 25. Ibraghimov-Beskrovnaya O, Dackowski WR, Foggensteiner L, Coleman N, Thiru S, Petry LR, Burn TC, Connors TD, Van Raay T, Bradley J, Qian F, Onuchic LF, Watnick TJ, Piontek K, Hakim RM, Landes GM, Germino GG, Sandford R, Klinger KW. Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci USA 94: 6397–6402, 1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Jin J, Desai BN, Navarro B, Donovan A, Andrews NC, Clapham DE. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science 322: 756–760, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Khandelwal P, Ruiz WG, Apodaca G. Compensatory endocytosis in bladder umbrella cells occurs through an integrin-regulated and RhoA- and dynamin-dependent pathway. EMBO J 29: 1961–1975, 2010 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. Kiselyov K, Chen J, Rbaibi Y, Oberdick D, Tjon-Kon-Sang S, Shcheynikov N, Muallem S, Soyombo A. TRP-ML1 is a lysosomal monovalent cation channel that undergoes proteolytic cleavage. J Biol Chem 280: 43218–43223, 2005 [DOI] [PubMed] [Google Scholar]
  • 29. Kottgen M, Buchholz B, Garcia-Gonzalez MA, Kotsis F, Fu X, Doerken M, Boehlke C, Steffl D, Tauber R, Wegierski T, Nitschke R, Suzuki M, Kramer-Zucker A, Germino GG, Watnick T, Prenen J, Nilius B, Kuehn EW, Walz G. TRPP2 and TRPV4 form a polymodal sensory channel complex. J Cell Biol 182: 437–447, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Krapivinsky G, Mochida S, Krapivinsky L, Cibulsky SM, Clapham DE. The TRPM7 ion channel functions in cholinergic synaptic vesicles and affects transmitter release. Neuron 52: 485–496, 2006 [DOI] [PubMed] [Google Scholar]
  • 31. Lewis SA. Everything you wanted to know about the bladder epithelium but were afraid to ask. Am J Physiol Renal Physiol 278: F867–F874, 2000 [DOI] [PubMed] [Google Scholar]
  • 32. Lewis SA, de Moura JL. Incorporation of cytoplasmic vesicles into apical membrane of mammalian urinary bladder epithelium. Nature 297: 685–688, 1982 [DOI] [PubMed] [Google Scholar]
  • 33. Lewis SA, Hanrahan JW. Apical and basolateral membrane ionic channels in rabbit urinary bladder epithelium. Pflügers Arch 405, Suppl 1: S83–S88, 1985 [DOI] [PubMed] [Google Scholar]
  • 34. Lindsey SH, Tribe RM, Songu-Mize E. Cyclic stretch decreases TRPC4 protein and capacitative calcium entry in rat vascular smooth muscle cells. Life Sci 83: 29–34, 2008 [DOI] [PubMed] [Google Scholar]
  • 35. Lohning C, Nowicka U, Frischauf AM. The mouse homolog of PKD1: sequence analysis and alternative splicing. Mamm Genome 8: 307–311, 1997 [DOI] [PubMed] [Google Scholar]
  • 36. Maroto R, Raso A, Wood TG, Kurosky A, Martinac B, Hamill OP. TRPC1 forms the stretch-activated cation channel in vertebrate cells. Nat Cell Biol 7: 179–185, 2005 [DOI] [PubMed] [Google Scholar]
  • 37. Min G, Zhou G, Schapira M, Sun TT, Kong XP. Structural basis of urothelial permeability barrier function as revealed by Cryo-EM studies of the 16 nm uroplakin particle. J Cell Sci 116: 4087–4094, 2003 [DOI] [PubMed] [Google Scholar]
  • 38. Mochizuki T, Sokabe T, Araki I, Fujishita K, Shibasaki K, Uchida K, Naruse K, Koizumi S, Takeda M, Tominaga M. The TRPV4 cation channel mediates stretch-evoked Ca2+ influx and ATP release in primary urothelial cell cultures. J Biol Chem 284: 21257–21264, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Morita H, Honda A, Inoue R, Ito Y, Abe K, Nelson MT, Brayden JE. Membrane stretch-induced activation of a TRPM4-like nonselective cation channel in cerebral artery myocytes. J Pharmacol Sci 103: 417–426, 2007 [DOI] [PubMed] [Google Scholar]
  • 40. Muraki K, Iwata Y, Katanosaka Y, Ito T, Ohya S, Shigekawa M, Imaizumi Y. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res 93: 829–838, 2003 [DOI] [PubMed] [Google Scholar]
  • 41. Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, Stokes AJ, Kurosaki T, Kinet JP, Penner R, Scharenberg AM, Fleig A. LTRPC7 is a Mg ATP-regulated divalent cation channel required for cell viability. Nature 411: 590–595, 2001 [DOI] [PubMed] [Google Scholar]
  • 42. Nauli SM, Alenghat FJ, Luo Y, Williams E, Vassilev P, Li X, Elia AE, Lu W, Brown EM, Quinn SJ, Ingber DE, Zhou J. Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells. Nat Genet 33: 129–137, 2003 [DOI] [PubMed] [Google Scholar]
  • 43. Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 87: 165–217, 2007 [DOI] [PubMed] [Google Scholar]
  • 44. Numata T, Shimizu T, Okada Y. Direct mechano-stress sensitivity of TRPM7 channel. Cell Physiol Biochem 19: 1–8, 2007 [DOI] [PubMed] [Google Scholar]
  • 45. Numata T, Shimizu T, Okada Y. TRPM7 is a stretch- and swelling-activated cation channel involved in volume regulation in human epithelial cells. Am J Physiol Cell Physiol 292: C460–C467, 2007 [DOI] [PubMed] [Google Scholar]
  • 46. Oancea E, Wolfe JT, Clapham DE. Functional TRPM7 channels accumulate at the plasma membrane in response to fluid flow. Circ Res 98: 245–253, 2006 [DOI] [PubMed] [Google Scholar]
  • 47. Roitbak T, Ward CJ, Harris PC, Bacallao R, Ness SA, Wandinger-Ness A. A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Mol Biol Cell 15: 1334–1346, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Rychkov G, Barritt GJ. TRPC1 Ca2+-permeable channels in animal cells. Handb Exp Pharmacol: 23–52, 2007 [DOI] [PubMed] [Google Scholar]
  • 49. Song X, Zhao Y, Narcisse L, Duffy H, Kress Y, Lee S, Brosnan CF. Canonical transient receptor potential channel 4 (TRPC4) co-localizes with the scaffolding protein ZO-1 in human fetal astrocytes in culture. Glia 49: 418–429, 2005 [DOI] [PubMed] [Google Scholar]
  • 50. Spector DA, Wade JB, Dillow R, Steplock DA, Weinman EJ. Expression, localization, and regulation of aquaporin-1 to -3 in rat urothelia. Am J Physiol Renal Physiol 282: F1034–F1042, 2002 [DOI] [PubMed] [Google Scholar]
  • 51. Stokes AJ, Shimoda LM, Koblan-Huberson M, Adra CN, Turner H. A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J Exp Med 200: 137–147, 2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Stotz SC, Vriens J, Martyn D, Clardy J, Clapham DE. Citral sensing by transient receptor potential channels in dorsal root ganglion neurons. PLoS One 3: e2082, 2008 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Strubing C, Krapivinsky G, Krapivinsky L, Clapham DE. TRPC1 and TRPC5 form a novel cation channel in mammalian brain. Neuron 29: 645–655, 2001 [DOI] [PubMed] [Google Scholar]
  • 54. Tian W, Salanova M, Xu H, Lindsley JN, Oyama TT, Anderson S, Bachmann S, Cohen DM. Renal expression of osmotically responsive cation channel TRPV4 is restricted to water-impermeant nephron segments. Am J Physiol Renal Physiol 287: F17–F24, 2004 [DOI] [PubMed] [Google Scholar]
  • 55. Wang EC, Lee JM, Johnson JP, Kleyman TR, Bridges R, Apodaca G. Hydrostatic pressure-regulated ion transport in bladder uroepithelium. Am J Physiol Renal Physiol 285: F651–F663, 2003 [DOI] [PubMed] [Google Scholar]
  • 56. Xu H, Fu Y, Tian W, Cohen DM. Glycosylation of the osmoresponsive transient receptor potential channel TRPV4 on Asn-651 influences membrane trafficking. Am J Physiol Renal Physiol 290: F1103–F1109, 2006 [DOI] [PubMed] [Google Scholar]
  • 57. Xu H, Zhao H, Tian W, Yoshida K, Roullet JB, Cohen DM. Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J Biol Chem 278: 11520–11527, 2003. [DOI] [PubMed] [Google Scholar]
  • 58. Yamada T, Ueda T, Shibata Y, Ikegami Y, Saito M, Ishida Y, Ugawa S, Kohri K, Shimada S. TRPV2 activation induces apoptotic cell death in human T24 bladder cancer cells: a potential therapeutic target for bladder cancer. Urology 76: 509 e501–e507, 2010 [DOI] [PubMed] [Google Scholar]
  • 59. Yamada T, Ugawa S, Ueda T, Ishida Y, Kajita K, Shimada S. Differential localizations of the transient receptor potential channels TRPV4 and TRPV1 in the mouse urinary bladder. J Histochem Cytochem 57: 277–287, 2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Yin J, Kuebler WM. Mechanotransduction by TRP channels: general concepts and specific role in the vasculature. Cell Biochem Biophys 56: 1–18 [DOI] [PubMed] [Google Scholar]
  • 61. Yu W, Khandelwal P, Apodaca G. Distinct apical and basolateral membrane requirements for stretch-induced membrane traffic at the apical surface of bladder umbrella cells. Mol Biol Cell 20: 282–295, 2009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62. Yu W, Zacharia LC, Jackson EK, Apodaca G. Adenosine receptor expression and function in bladder uroepithelium. Am J Physiol Cell Physiol 291: C254–C265, 2006 [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Physiology - Renal Physiology are provided here courtesy of American Physiological Society

RESOURCES